Form 8-K - Current report:
SEC Accession No. 0001641172-25-018313
Filing Date
2025-07-09
Accepted
2025-07-09 08:45:26
Documents
16
Period of Report
2025-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45656
2 EX-99.2 ex99-2.htm EX-99.2 15255
3 GRAPHIC ex99-2_001.jpg GRAPHIC 17152
4 GRAPHIC ex99-2_002.jpg GRAPHIC 29090
  Complete submission text file 0001641172-25-018313.txt   297297

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pali-20250702.xsd EX-101.SCH 3023
6 XBRL LABEL FILE pali-20250702_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE pali-20250702_pre.xml EX-101.PRE 22364
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3721
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 251112350
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)